Powering the Prevention Shift - Compelling New Data Shows Rapid ROI for Every ICB

The NHS Oversight Framework published last week reveals ambitious secondary prevention targets - setting the number of additional patients in every ICB whose blood pressure and cholesterol treatment must be optimised.

Historically, under treatment in secondary prevention is widespread and longstanding, and despite years of improvement activity and incentives, overall gains remain marginal.  CVDACTION has been built to challenge this history and enable step change improvement.

We've just updated the CVDACTION Impact Model and the numbers are compelling. A realistic step change in uptake of secondary prevention medicines (for high blood pressure, cholesterol, diabetes and chronic kidney disease) would have a powerful impact in just 3 years:

• Prevent 57,000 heart attacks, strokes, episodes of heart failure and kidney failure

• Free 430,000 bed days (that’s 2 hospitals emptied for a year!)

• Save £1.1 billion in NHS and social care spend

• Generate £1.2 billion in economic growth

• £1 invested returns £14 in 3 years with ICBs breaking even within 12 months 

Our report detailing impact for every ICB in the country can be viewed here:

The time to act is now. Contact us today to learn how CVDACTION can transform care and deliver economic benefits.